TY - JOUR T1 - Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans JF - Drug Metabolism and Disposition JO - Drug Metab Dispos SP - 718 LP - 728 DO - 10.1124/dmd.121.000513 VL - 49 IS - 9 AU - Shiori Honda AU - Tatsuki Fukami AU - Keiya Hirosawa AU - Takuya Tsujiguchi AU - Yongjie Zhang AU - Masataka Nakano AU - Shotaro Uehara AU - Yasuhiro Uno AU - Hiroshi Yamazaki AU - Miki Nakajima Y1 - 2021/09/01 UR - http://dmd.aspetjournals.org/content/49/9/718.abstract N2 - For drug development, species differences in drug-metabolism reactions present obstacles for predicting pharmacokinetics in humans. We characterized the species differences in hydrolases among humans and mice, rats, dogs, and cynomolgus monkeys. In this study, to expand the series of such studies, we attempted to characterize marmoset hydrolases. We measured hydrolase activities for 24 compounds using marmoset liver and intestinal microsomes, as well as recombinant marmoset carboxylesterase (CES) 1, CES2, and arylacetamide deacetylase (AADAC). The contributions of CES1, CES2, and AADAC to hydrolysis in marmoset liver microsomes were estimated by correcting the activities by using the ratios of hydrolase protein levels in the liver microsomes and those in recombinant systems. For six out of eight human CES1 substrates, the activities in marmoset liver microsomes were lower than those in human liver microsomes. For two human CES2 substrates and three out of seven human AADAC substrates, the activities in marmoset liver microsomes were higher than those in human liver microsomes. Notably, among the three rifamycins, only rifabutin was hydrolyzed by marmoset tissue microsomes and recombinant AADAC. The activities for all substrates in marmoset intestinal microsomes tended to be lower than those in liver microsomes, which suggests that the first-pass effects of the CES and AADAC substrates are due to hepatic hydrolysis. In most cases, the sums of the values of the contributions of CES1, CES2, and AADAC were below 100%, which indicated the involvement of other hydrolases in marmosets. In conclusion, we clarified the substrate preferences of hydrolases in marmosets.SIGNIFICANCE STATEMENT This study confirmed that there are large differences in hydrolase activities between humans and marmosets by characterizing marmoset hydrolase activities for compounds that are substrates of human CES1, CES2, or arylacetamide deacetylase. The data obtained in this study may be useful for considering whether marmosets are appropriate for examining the pharmacokinetics and efficacies of new chemical entities in preclinical studies. ER -